Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LIXT US Equity

Lixte Biotechnology Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1335105 · FY ends Dec 31
$4.22
+0.17 (+4.20%)
USD · as of 2026-08-18 · marketstack
2 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-07-3113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-318-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-108-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-10

Every row is a filed document, checked against its EDGAR index.